Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07446478 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TIS for Improving Cognitive Impairment Associated With Schizophrenia

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 5 more changesShow less
    • Primary completion date changed from estimate of Aug 1, 2026 to Sep 16, 2026
    • Study completion date changed from estimate of Aug 15, 2026 to Sep 20, 2026
    • Eligibility criteria expanded, about 16 words
    • Secondary endpoints: details revised at 3 of 7 entries
    • Site details revised
  2. Recruitment openedv3 Show 4 more changesShow less
    • Start date changed from estimate of Mar 15, 2026 to Jun 24, 2026
    • Primary completion pushed from May 1, 2026 to Aug 1, 2026
    • Study completion pushed from May 15, 2026 to Aug 15, 2026
    • Site details revised
  3. Secondary endpoints: 6 to 7v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the efficacy and safety of TIS targeting the hippocampus in ameliorating cognitive impairment associated with schizophrenia (CIAS). Participants will receive TIS twice a day for 2 weeks. Their clinical data, including the baseline clinical symptom scale score, cognitive function, and MRI data, will be collected at baseline and at the end of the 2-week intervention.
Trial Details
NCT Number NCT07446478
Lead Sponsor Central South University
Conditions
(from sponsor)		 Cognitive Impairment Associated With Schizophrenia (CIAS)
Related terms Cognitive Dysfunction, Schizophrenia
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov